Login
← Go Back
Sequent Scientific
SEQUENT · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in
Stock Price vs Company Growth
1d
2.1%
1w
5.9%
1m
8.5%
3m
3.0%
6m
46.3%
1y
55.3%
5y
20.0%
all
0.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 178 2.1%
165
241
Company Overview
Sales
1,449 Cr
Growth: 3.4%
Profit after Tax
13.7 Cr
Growth: -356.7%
Small Cap
4,468 Cr
P/E: 274.6x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 1,449
Growth 3.4%
EBITDA 9.4%
P/S 3.1x
Dividend 0.0%
P/E 274.6x
Book Value ₹ 26.6
PEG Ratio 81.3x
ROE 2.1%
P/B 6.7x
Shareholding Pattern
Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Others
Increase    Decrease    No change
Company Profile Detailed
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Belongs to (7 Indices) view more
Investors (90)
dilip.sh...
harish.n...
kalpana....
Followers (7)
jose4
joy2
ratnesh2